Doctor profile · Federal record
Dr. Sivaramya Kollipara, M.D.
Dermatology Physician · Dallas, TX
- NPI 1295179190
- MIPS 98.3 / 100 · 2023
- 13 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5445 la Sierra Dr Ste 102
Dallas, TX 752313464
(636) 527-9999 - Mailing address
-
3601 4Th St, Texas Tech University Health Sciences Center Gme
Lubbock, TX 794309400
Credentials & registration
- NPI registered
- April 2013 — 13 yrs on file
- Profile last updated
- August 26, 2019
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #Q1435
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295179190. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
324
Distinct HCPCS
10
Medicare allowed
$32,395
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 74 | 16 | $7 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 49 | 21 | $110 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 38 | 32 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 31 | 28 | $54 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 22 | 22 | $160 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 19 | 19 | $108 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 18 | 16 | $124 | |
11102 |
Biopsy of related skin growth, first growth | 17 | 17 | $84 | |
J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 17 | 14 | $385 | |
17110 |
Destruction of skin growth, 1-14 growths | 13 | 13 | $106 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 1.5× the peer median.Open Payments
Industry payments received
All-time total
$976
Transactions
41
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 13 | $287.39 | |
| Janssen Biotech, INC. | 4 | $167.79 | |
| Regeneron Healthcare Solutions, INC. | 7 | $141.10 | |
| Leo Pharma INC. | 4 | $91.53 | |
| Almirall LLC | 2 | $58.64 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $40.67 | |
| Sun Pharmaceutical Industries INC. | 1 | $38.52 | |
| Novartis Pharmaceuticals Corporation | 1 | $34.37 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 2 | $32.90 | |
| Amgen INC. | 1 | $23.57 | |
| Incyte Corporation | 1 | $19.80 | |
| Lilly USA, LLC | 1 | $15.63 | |
| Genzyme Corporation | 1 | $13.60 | |
| Mayne Pharma Commercial LLC | 1 | $10.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
178
Patients
83
Total drug cost
$4,089
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocortisone | Generic | 42 | 25 | $319 |
| Ketoconazole | Generic | 36 | 17 | $582 |
| Triamcinolone Acetonide | Generic | 31 | 27 | $473 |
| Nystatin | Generic | 26 | 0 | $364 |
| Clobetasol Propionate | Generic | 18 | 14 | $1,168 |
| Clindamycin Phosphate | Generic | 13 | 0 | $888 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 12 | 0 | $295 |
Frequently asked questions
What is Dr. Sivaramya Kollipara's medical specialty?
Dr. Sivaramya Kollipara practices Dermatology Physician in Dallas, TX.
Where does Dr. Sivaramya Kollipara practice?
Dr. Sivaramya Kollipara practices at 5445 la Sierra Dr Ste 102, Dallas, TX 752313464. Office phone: 6365279999.
What is Dr. Sivaramya Kollipara's NPI?
Dr. Sivaramya Kollipara's National Provider Identifier (NPI) is 1295179190, issued by NPPES.
What procedures does Dr. Sivaramya Kollipara commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS 96910); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.